Literature DB >> 10385888

Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography.

Y Kim1, J W Kim, K Ito, H S Lim, H K Cheong, J Y Kim, Y C Shin, K S Kim, Y Moon.   

Abstract

It is difficult to distinguish manganism from idiopathic parkinsonism by clinical signs only. Case history and examination: A 48-year-old welder for over 10 years complained of masked face, right side (arm and leg) resting tremor, and bradykinesia for over one year. Magnetic resonance imaging (MRI) findings showed symmetrical high signal intensities in the globus pallidus on T1 weighted image. These intensities disappeared almost completely six months after cessation of exposure. 18F-6-fluorodopa (18F-dopa) positron emission tomography (PET) findings showed reduced 18F-dopa uptake in the left putamen, findings which appear in idiopathic parkinsonism. A PET study is necessary to distinguish manganism from idiopathic parkinsonism, especially in a working environment with elevated Mn concentrations, such as welding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385888

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  25 in total

1.  Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure.

Authors:  Yueming Jiang; Wei Zheng; Liling Long; Weijia Zhao; Xiangrong Li; Xuean Mo; Jipei Lu; Xue Fu; Wenmei Li; Shouting Liu; Quanyong Long; Jinli Huang; Enrico Pira
Journal:  Neurotoxicology       Date:  2006-08-22       Impact factor: 4.294

Review 2.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

Review 3.  Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.

Authors:  Jerome A Roth
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

4.  Neuromythology of Manganism.

Authors:  Kristin M Andruska; And Brad A Racette
Journal:  Curr Epidemiol Rep       Date:  2015-06

5.  Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine.

Authors:  Adrienne P Stephenson; Jeffrey A Schneider; Bryant C Nelson; Donald H Atha; Ashok Jain; Karam F A Soliman; Michael Aschner; Elizabeth Mazzio; R Renee Reams
Journal:  Toxicol Lett       Date:  2013-01-04       Impact factor: 4.372

6.  Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.

Authors:  Rosemarie M Bowler; Harry A Roels; Sanae Nakagawa; Marija Drezgic; Emily Diamond; Robert Park; William Koller; Russell P Bowler; Donna Mergler; Maryse Bouchard; Donald Smith; Roberto Gwiazda; Richard L Doty
Journal:  Occup Environ Med       Date:  2006-10-03       Impact factor: 4.402

7.  Pathophysiology of manganese-associated neurotoxicity.

Authors:  Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng
Journal:  Neurotoxicology       Date:  2011-12-21       Impact factor: 4.294

Review 8.  From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.

Authors:  Roberto G Lucchini; Christopher J Martin; Brent C Doney
Journal:  Neuromolecular Med       Date:  2009-12-10       Impact factor: 3.843

9.  Occupational neurologic disorders in Korea.

Authors:  Yangho Kim; Kyoung Sook Jeong; Yong-Hun Yun; Myoung-Soon Oh
Journal:  J Clin Neurol       Date:  2010-06-30       Impact factor: 3.077

10.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.